These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 27196490)

  • 1. Oncologic Safety of Local Excision Compared With Total Mesorectal Excision for ypT0-T1 Rectal Cancer: A Propensity Score Analysis.
    Jung SM; Yu CS; Park IJ; Kim TW; Kim JH; Yoon YS; Lim SB; Kim JC
    Medicine (Baltimore); 2016 May; 95(20):e3718. PubMed ID: 27196490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total Mesorectal Excision Versus Local Excision After Preoperative Chemoradiotherapy in Rectal Cancer With Lymph Node Metastasis: A Propensity Score-Matched Analysis.
    Shin YS; Park JH; Yoon SM; Kim JC; Yu CS; Lim SB; Park IJ; Kim TW; Hong YS; Kim KP; Choi EK; Ahn SD; Lee SW; Kim JH
    Int J Radiat Oncol Biol Phys; 2018 Jul; 101(3):630-639. PubMed ID: 29678529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Term Outcome of Rectal Cancer With Clinically (EUS/MRI) Metastatic Mesorectal Lymph Nodes Treated by Neoadjuvant Chemoradiation: Role of Organ Preservation Strategies in Relation to Pathologic Response.
    Belluco C; Forlin M; Olivieri M; Cannizzaro R; Canzonieri V; Buonadonna A; Bidoli E; Matrone F; Bertola G; De Paoli A
    Ann Surg Oncol; 2016 Dec; 23(13):4302-4309. PubMed ID: 27489059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total Mesorectal Excision Versus Local Excision After Favorable Response to Preoperative Chemoradiotherapy in "Early" Clinical T3 Rectal Cancer: A Propensity Score Analysis.
    Shin YS; Yu CS; Park JH; Kim JC; Lim SB; Park IJ; Kim TW; Hong YS; Kim KP; Yoon SM; Joo JH; Kim JH
    Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):136-144. PubMed ID: 28816139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of oncologic outcomes of metastatic rectal cancer patients with or without neoadjuvant chemoradiotherapy.
    Kim SH; Kim JH; Jung SH
    Int J Colorectal Dis; 2015 Sep; 30(9):1193-9. PubMed ID: 26072129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Adjuvant Chemotherapy in ypT0-2N0 Patients Treated with Preoperative Chemoradiation Therapy and Radical Resection for Rectal Cancer.
    Park IJ; Kim DY; Kim HC; Kim NK; Kim HR; Kang SB; Choi GS; Lee KY; Kim SH; Oh ST; Lim SB; Kim JC; Oh JH; Kim SY; Lee WY; Lee JB; Yu CS
    Int J Radiat Oncol Biol Phys; 2015 Jul; 92(3):540-7. PubMed ID: 26068489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poorer Oncologic Outcome of Good Responders to PCRT With Remnant Lymph Nodes Defies the Oncologic Paradox in Patients With Rectal Cancer.
    Cho E; Park IJ; Hong SM; Lee JL; Kim CW; Yoon YS; Lim SB; Yu CS; Kim JC
    Clin Colorectal Cancer; 2019 Jun; 18(2):e171-e178. PubMed ID: 31027968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of clinical and pathological stages on locally advanced rectal carcinoma after neoadjuvant chemoradiotherapy.
    Wen B; Zhang L; Wang C; Huang R; Peng H; Zhang T; Dong J; Xiao W; Zeng Z; Liu M; Gao Y
    Radiat Oncol; 2015 Jun; 10():124. PubMed ID: 26040453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local excision after neoadjuvant chemoradiotherapy versus total mesorectal excision: a case-matched study in 110 selected high-risk patients with rectal cancer.
    Calmels M; Collard MK; Cazelles A; Frontali A; Maggiori L; Panis Y
    Colorectal Dis; 2020 Dec; 22(12):1999-2007. PubMed ID: 32813899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of lymph node metastases in patients with ypT0-2 rectal cancers after neoadjuvant chemoradiotherapy.
    Park IJ; You YN; Skibber JM; Rodriguez-Bigas MA; Feig B; Nguyen S; Hu CY; Chang GJ
    Dis Colon Rectum; 2013 Feb; 56(2):135-41. PubMed ID: 23303140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trial.
    Breugom AJ; van Gijn W; Muller EW; Berglund Å; van den Broek CBM; Fokstuen T; Gelderblom H; Kapiteijn E; Leer JWH; Marijnen CAM; Martijn H; Meershoek-Klein Kranenbarg E; Nagtegaal ID; Påhlman L; Punt CJA; Putter H; Roodvoets AGH; Rutten HJT; Steup WH; Glimelius B; van de Velde CJH
    Ann Oncol; 2015 Apr; 26(4):696-701. PubMed ID: 25480874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local excision after preoperative chemoradiation results in an equivalent outcome to total mesorectal excision in selected patients with T3 rectal cancer.
    Callender GG; Das P; Rodriguez-Bigas MA; Skibber JM; Crane CH; Krishnan S; Delclos ME; Feig BW
    Ann Surg Oncol; 2010 Feb; 17(2):441-7. PubMed ID: 19847569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lymph node metastases in ypT1/2 rectal cancer after neoadjuvant chemoradiotherapy : The Achilles heel of organ-preserving operative procedures?].
    Sprenger T; Rothe H; Beissbarth T; Conradi LC; Kauffels A; Homayounfar K; Behnes CL; Rödel C; Liersch T; Ghadimi M
    Chirurg; 2016 Jul; 87(7):593-601. PubMed ID: 27106241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Plane of Total Mesorectal Excision With Prognosis of Rectal Cancer: Secondary Analysis of the CAO/ARO/AIO-04 Phase 3 Randomized Clinical Trial.
    Kitz J; Fokas E; Beissbarth T; Ströbel P; Wittekind C; Hartmann A; Rüschoff J; Papadopoulos T; Rösler E; Ortloff-Kittredge P; Kania U; Schlitt H; Link KH; Bechstein W; Raab HR; Staib L; Germer CT; Liersch T; Sauer R; Rödel C; Ghadimi M; Hohenberger W;
    JAMA Surg; 2018 Aug; 153(8):e181607. PubMed ID: 29874375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-Reactive Protein Level Predicts Survival Outcomes in Rectal Cancer Patients Undergoing Total Mesorectal Excision After Preoperative Chemoradiation Therapy.
    Kim WR; Han YD; Min BS
    Ann Surg Oncol; 2018 Dec; 25(13):3898-3905. PubMed ID: 30288654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrence rates and prognostic factors in ypN0 rectal cancer after neoadjuvant chemoradiation and total mesorectal excision.
    Govindarajan A; Reidy D; Weiser MR; Paty PB; Temple LK; Guillem JG; Saltz LB; Wong WD; Nash GM
    Ann Surg Oncol; 2011 Dec; 18(13):3666-72. PubMed ID: 21590450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival analysis of local excision vs total mesorectal excision for middle and low rectal cancer in pT1/pT2 stage and intermediate pathological risk.
    Lai IL; You JF; Chern YJ; Tsai WS; Chiang JM; Hsieh PS; Hung HY; Yeh CY; Chiang SF; Lai CC; Tang RP; Chen JS; Hsu YJ
    World J Surg Oncol; 2019 Dec; 17(1):212. PubMed ID: 31818295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathological complete response may underestimate distant metastasis in locally advanced rectal cancer following neoadjuvant chemoradiotherapy and radical surgery: Incidence, metastatic pattern, and risk factors.
    Sun Y; Wu X; Zhang Y; Lin H; Lu X; Huang Y; Chi P
    Eur J Surg Oncol; 2019 Jul; 45(7):1225-1231. PubMed ID: 30879932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local excision of low rectal cancer treated by chemoradiotherapy: is it safe for all patients with suspicion of complete tumor response?
    Debove C; Guedj N; Tribillon E; Maggiori L; Zappa M; Panis Y
    Int J Colorectal Dis; 2016 Apr; 31(4):853-60. PubMed ID: 26951185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preoperative chemoradiotherapy for rectal cancer: experience from one centre].
    Lescut N; Lepinoy A; Schipman B; Cerda T; Guimas V; Bednarek C; Bosset JF
    Cancer Radiother; 2015 Apr; 19(2):98-105. PubMed ID: 25769650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.